Joint Development of Nano-Carrier Delivery System for miR Mimetic Technology to Treat Cancer to Be Partially Funded by Israel’s Office of the Chief Scientist Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company has entered into a sponsored research agreement with ), a Company … (more)
